•
Sep 30, 2018

Boston Scientific Q3 2018 Earnings Report

Total Revenue
$2.39B
Previous year: $2.22B
+7.7%
EPS
$0.35
Previous year: $0.31
+12.9%
Gross Profit
$1.7B
Previous year: $1.57B
+8.6%
Cash and Equivalents
$168M
Previous year: $210M
-20.0%
Free Cash Flow
$425M
Previous year: $195M
+117.9%
Total Assets
$20.4B
Previous year: $18.6B
+9.4%

Boston Scientific

Boston Scientific